Nanoparticles and Antiviral Vaccines

Area of Science:

• Virology and Immunology
• Nanotechnology in Vaccine Development

Background:

• Viruses pose significant threats, causing diverse infections and necessitating robust human immune responses and effective vaccines.
• Traditional vaccines vary in safety and efficacy; advancements in biochemistry and biophysics drive innovation in vaccine design.

Purpose of the Study:

• To review major pathogenic viruses, pandemics, and historical vaccine development.
• To summarize characteristics of antiviral vaccines and adjuvants.
• To explore recent advances in nanoparticle-based next-generation antiviral vaccines.

Main Methods:

• Literature review of pathogenic viruses, pandemics, and vaccine characteristics.
• Analysis of nanoparticle applications in vaccine development, including self-assembling protein polymers, virus-like particles, nano-carriers, and nano-adjuvants.
• Discussion of nanoparticle potential for mucosal and broad-spectrum vaccines.

Main Results:

• Detailed description of major viruses and pandemics over the past two centuries.
• Summary of diverse antiviral vaccine types and adjuvants.
• Exploration of nanoparticle applications in vaccines against influenza, coronaviruses, HIV, and hepatitis viruses.

Conclusions:

• Nanoparticle technology presents a promising platform for developing next-generation antiviral vaccines.
• These platforms hold potential for creating broad-spectrum, preventive, and therapeutic vaccines.
• Nanoparticles may enhance the development of safe and effective mucosal vaccines.